33
Participants
Start Date
February 7, 2018
Primary Completion Date
December 30, 2021
Study Completion Date
March 24, 2022
MK3475
anti-PD1 immunotherapy
Samsung Medical Center, Seoul
Samsung Medical Center
OTHER